Pharmaceutical

Avricore Health Makes the Grade on 2023 TSX Venture 50

Avricore Health Makes the Grade on 2023 TSX Venture 50

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange's list of top performing companies.

"To make the Venture 50 feels great and the whole team is excited to keep delivering on our promise to build the world's largest rapid-testing network in pharmacy," said Hector Bremner, CEO of Avricore Health. "Thank you to all our partners and supporters for helping us make this dream of success become a reality!"

Avricore was selected out of over 1700 businesses currently listed on the TSX Venture Exchange for its stellar growth in market capitalization, share price appreciation and trading volume. Driving these results is the scale up and expansion of HealthTab, the Company's point-of-care testing platform, which is on track to becoming the world's largest, most reliable network in community pharmacies.

The Company's current plans are expected to see HealthTab in hundreds of new locations and even new countries, which is expected to drive significant increases in revenues. This means last year's successes will continue to be the trend.

To hear more about this exciting story, visit www.avricore.com and see our TSX Venture 50 video here .

HealthTab™ Market Fast Facts

  • Point of Care Testing Market to reach $93.21 Billion USD in 2030 ( Source )
  • Nearly 13.6 Million Canadians expected to be diabetic or prediabetic by 2030, with many undiagnosed ( Source )
  • Over 1 in 3 Americans, approximately 88 million people, have pre-diabetes ( Source )
  • Close to 160,000 Canadians 20 years and older are diagnosed with heart disease each year, often it's only after a heart attack they are diagnosed. ( Source )
  • There are more that 10,000 pharmacies in Canada, 88,000 pharmacies in the US, nearly 12,000 in the UK.

About HealthTab™

HealthTab™ is a turnkey point-of-care testing solution that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). HealthTab™ has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19.

The HealthTab™ network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery, while empowering patients to take more control of their health. It also reduces costs and waiting times and provides many potential revenue streams including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets, and third-party app integration through API.

About Avricore Health Inc.

Avricore Health Inc. (TSXV: AVCR) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab™, a wholly owned subsidiary, the Company's mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

Contact :

Avricore Health Inc.
Hector Bremner, CEO 604-773-8943
info@avricorehealth.com
www.avricorehealth.com

Cautionary Note Regarding Forward-Looking Statements
Information in this press release that involves Avricore Health's expectations, plans, intentions, or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. Avricore Health generally uses words such as "outlook," "will," "could," "would," "might," "remains," "to be," "plans," "believes," "may," "expects," "intends," "anticipates," "estimate," "future," "positioned," "potential," "project," "remain," "scheduled," "set to," "subject to," "upcoming," and similar expressions to help identify forward-looking statements. In this press release, forward-looking statements include statements regarding: the completion of the placement and the expected timing thereof and the Company's expected use of proceeds from the placement; the unique features that the HealthTab™ platform offers to pharmacists and patients. Forward-looking statements reflect the then-current expectations, beliefs, assumptions, estimates and forecasts of Avricore Health's management. The forward-looking statements in this press release are based upon information available to Avricore Health as of the date of this press release. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of Avricore Health and are subject to a few risks, uncertainties, and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations, including without limitation: failure to meet regulatory requirements; changes in the market; potential downturns in economic conditions; and other risk factors described in Avricore's public filings. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

AVCR:CA
The Conversation (0)
avricore

Avricore Health


Keep reading...Show less
Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection

Avricore Health's HealthTab Passes 530 Locations, Adds Virus Detection

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott's ID Now™, either in combination with the Afinion 2™ or standalone, to support virus detection and assess the demand and effectiveness of infectious disease screening in community pharmacies.

"We are seeing significant demand for HealthTab as the pharmacist scope of practice expansion takes effect and the anticipation of expanded healthcare funding," said Hector Bremner, CEO of Avricore Health Inc. "We look forward to continuing our steady growth and adding value to our offering, such as the new testing options which ID Now brings."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of this effort the Company is pleased to provide insight into the successes of last year and lay out updates and objectives on further progress.

"Last year we set out bold targets and today we can demonstrate we've been able to achieve them," said Hector Bremner, CEO of Avricore Health Inc. "There's no doubt that we are poised for significant growth in 2023 and beyond."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Avricore Health Reports Third-Quarter 2022 Results

Avricore Health Reports Third-Quarter 2022 Results

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives.

The Company's objective to create the world's first cloud-connected point-of-care network in community pharmacy is on track to becoming a reality, bringing powerful health screening and data management tools to community pharmacies and ensuring better outcomes for patients.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Avricore to Present at Emerging Growth Conference on Oct. 26, 2022

Avricore to Present at Emerging Growth Conference on Oct. 26, 2022

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") is excited to present at the Emerging Growth Conference on October 26 th .

This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Hector Bremner in real time on the Company's current activities. After a short presentation, the floor will be subsequently opened for questions, where Mr. Bremner will do his best to get through as many of them as possible.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
HealthTab Roll Out on Track and Operations Cashflow Positive

HealthTab Roll Out on Track and Operations Cashflow Positive

Avricore Health INC. (TSXV: AVCR) (the " Company " or " AVCR ") is pleased to provide this corporate update on the Company's execution expanding its powerful chronic-disease screening and reporting platform, HealthTab.

On August 8 th , the Company announced a new Master Service Agreement and Statement of Work was signed with Shoppers Drug Mart pharmacies to significantly expand the HealthTab point-of-care testing platform to up to 450 locations nation-wide, with affiliated locations under the Loblaw family of brands being included.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Nano One Provides Quarterly Progress Update and Reports Q4 2022 Results

Nano One Provides Quarterly Progress Update and Reports Q4 2022 Results

TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) nano one® Materials Corp. ("nano one" or the "Company") is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries. nano one has filed its audited annual consolidated financial statements (the "financial statements"), management's discussion & analysis ("MD&A"), and annual information form ("AIF") as at and for the year ended December 31, 2022 ("Q4 2022") and is pleased to provide the following highlights from Q4 2022

Q4 2022 Highlights and Headlines

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market

Company to target New key market segments identified as high growth opportunities

Arway Corporation ("Arway" or the "Company") (CSE:ARWY)(OTC:ARWYF)(FSE:E65) is an AI-powered augmented reality experience platform for indoor spaces with a disruptive no-code, no beacon spatial computing solution with centimeter precision, is pleased to announce the Company has signed five new deals for its Software Development Kit (SDK), which showcases the increasing demand for this disruptive technology. Since the SDK was released on January 31, 2023 the Company has been experiencing a wave of demand from resellers, enterprise corporations and brands. These SDK deals range in size from $9,000-$15,000 based on the usage of the platform, and are within various industries representing a wide range of use cases for Arway technology

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-commerce

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-commerce

Multiple New Enterprise Accounts Driving 2023 Sales Growth As Company Pushes Towards Going Cash Flow Positive

Nextech3D.AI (formerly NexTech AR Solutions Corp) (OTCQX:NEXCF) (CSE:NTAR) (FSE:EP2), a leading Generative AI-Powered 3D modeling supplier for major e-commerce brands such as Amazon, P&G, Kohls, and Dyson, has announced a significant expansion into the Asian market with a major enterprise 3D modeling deal for thousands of product SKUs. The contract highlights Nextech's breakthrough Generative AI technology, which is emerging as a globally dominant AI solution for scaling the production of 3D models in the booming e-commerce industry. The production of 3D models for ecommerce is estimated to be worth $100billion

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
"emerging technologies" written on keyboard

Top 10 Emerging Technologies to Watch in 2023

Although the COVID-19 pandemic and global economic challenges have disrupted businesses in recent years, companies continue to look for new opportunities in emerging technologies and for innovations that can reshape the world.

In its Top 10 Strategic Technology Trends for 2023 report, technological research and consulting firm Gartner examines the top tech innovations that its analysts believe will have the greatest impact on how successful businesses are in maintaining a positive financial position and operational excellence as this era of digital transformation continues to accelerate. The report includes a list of the top emerging technologies to watch this year, and Gartner indicates that they could be key to sustainable enterprise growth.

A major theme in the report is the rise of technologies that will help businesses address four key priorities: optimizing resilience, operations or trust; scaling productivity and customer value by advancing solutions, product delivery and connectivity; pioneering customer engagement, accelerated responses or opportunity; and pursuing sustainable technology solutions.

Keep reading...Show less
ARway.ai Unveils Patent-Pending AI-powered 3D Digital Twin Floor Plan Generation Technology to Capture a Share of the $44 Billion Indoor Navigation Market

ARway.ai Unveils Patent-Pending AI-powered 3D Digital Twin Floor Plan Generation Technology to Capture a Share of the $44 Billion Indoor Navigation Market

AI-created 3D spatial replicas are now readily available and easy to create from any 2D floor plan

Arway Corporation ("Arway" or the "Company") (CSE:ARWY)(OTC PINK:ARWYF)(FSE:E65) is an AI-powered augmented reality experience platform for indoor spaces with a disruptive no-code, no beacon spatial computing solution with centimeter precision. Arway.ai's new breakthrough automates the creation of 3D spatial maps from just 2D floor plans creating a digital twin which can be populated with an array of AR experiences. The Company now offers AI-powered floor plan alignment, positioning & re-localization, and expanded map analytics capabilities. The Company believes these enhancements will contribute to its continual increase in market share of the estimated $42 billion global indoor positioning and indoor navigation (IPIN) market. Arway has unlimited use cases for augmenting physical spaces in the metaverse, making it a valuable tool for creators, brands, and companies in various industries

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nextech3D.ai to Present its Generative AI-Powered 3D Modeling Solutions at the Virtual Investor Summit on March 29

Nextech3D.ai to Present its Generative AI-Powered 3D Modeling Solutions at the Virtual Investor Summit on March 29

Nextech3D.AI (formally "NexTech AR Solutions Corp" or the "Company") (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohls and other major e-commerce retailers is pleased to announce that CEO Evan Gappelberg will present on March 29, 2023 at Virtual Investor Summit Microcap Event

This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Evan Gappelberg in real time.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×